Mary Alexis Iaccarino, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Concussion | 14 | 2023 | 1320 | 2.280 |
Why?
|
| Brain Injuries | 4 | 2023 | 2025 | 0.670 |
Why?
|
| Magnetic Field Therapy | 1 | 2017 | 28 | 0.590 |
Why?
|
| Accidents, Traffic | 2 | 2021 | 819 | 0.570 |
Why?
|
| Education | 1 | 2019 | 543 | 0.540 |
Why?
|
| Hemianopsia | 1 | 2017 | 122 | 0.530 |
Why?
|
| Post-Concussion Syndrome | 1 | 2018 | 219 | 0.520 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2020 | 3658 | 0.510 |
Why?
|
| Athletic Injuries | 3 | 2019 | 1154 | 0.500 |
Why?
|
| Myofascial Pain Syndromes | 1 | 2014 | 35 | 0.480 |
Why?
|
| Methylphenidate | 1 | 2018 | 473 | 0.470 |
Why?
|
| Nervous System Diseases | 2 | 2020 | 1623 | 0.430 |
Why?
|
| Central Nervous System Stimulants | 1 | 2018 | 1148 | 0.340 |
Why?
|
| Bicycling | 2 | 2021 | 176 | 0.340 |
Why?
|
| Recovery of Function | 2 | 2020 | 2925 | 0.330 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 3611 | 0.290 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3132 | 0.260 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3239 | 0.260 |
Why?
|
| Craniocerebral Trauma | 2 | 2019 | 482 | 0.260 |
Why?
|
| Pediatrics | 2 | 2019 | 3469 | 0.250 |
Why?
|
| Telemedicine | 3 | 2023 | 2872 | 0.170 |
Why?
|
| Internship and Residency | 1 | 2019 | 5787 | 0.160 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2019 | 230 | 0.150 |
Why?
|
| Military Personnel | 2 | 2023 | 1133 | 0.140 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2017 | 48 | 0.140 |
Why?
|
| Exotropia | 1 | 2017 | 55 | 0.140 |
Why?
|
| Blepharoptosis | 1 | 2017 | 144 | 0.130 |
Why?
|
| Central Nervous System Agents | 1 | 2016 | 72 | 0.130 |
Why?
|
| Bibliometrics | 1 | 2019 | 339 | 0.130 |
Why?
|
| Transdermal Patch | 1 | 2014 | 51 | 0.120 |
Why?
|
| Placebo Effect | 1 | 2018 | 502 | 0.120 |
Why?
|
| Humans | 29 | 2023 | 744220 | 0.120 |
Why?
|
| Tramadol | 1 | 2014 | 51 | 0.120 |
Why?
|
| Muscle Relaxants, Central | 1 | 2014 | 86 | 0.110 |
Why?
|
| Physician's Role | 1 | 2020 | 942 | 0.110 |
Why?
|
| Fear | 1 | 2021 | 1439 | 0.110 |
Why?
|
| Exercise Therapy | 1 | 2020 | 906 | 0.110 |
Why?
|
| Aftercare | 1 | 2018 | 866 | 0.100 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2014 | 161 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 7281 | 0.100 |
Why?
|
| Publishing | 1 | 2019 | 833 | 0.100 |
Why?
|
| Adolescent | 7 | 2021 | 85759 | 0.100 |
Why?
|
| Sports | 1 | 2018 | 688 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2015 | 63119 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 1 | 2021 | 2732 | 0.100 |
Why?
|
| Lidocaine | 1 | 2014 | 544 | 0.100 |
Why?
|
| Hemodynamics | 1 | 2021 | 4199 | 0.090 |
Why?
|
| Pandemics | 2 | 2020 | 8387 | 0.090 |
Why?
|
| Physical Therapy Modalities | 1 | 2014 | 550 | 0.090 |
Why?
|
| Acupuncture Therapy | 1 | 2014 | 464 | 0.090 |
Why?
|
| Female | 10 | 2021 | 380197 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 3395 | 0.080 |
Why?
|
| Health Promotion | 1 | 2020 | 2205 | 0.080 |
Why?
|
| Anxiety | 1 | 2021 | 4297 | 0.070 |
Why?
|
| Analgesics | 1 | 2014 | 1040 | 0.070 |
Why?
|
| Public Health | 1 | 2020 | 2603 | 0.070 |
Why?
|
| Exercise | 2 | 2021 | 5615 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 3923 | 0.060 |
Why?
|
| Adult | 7 | 2021 | 214035 | 0.060 |
Why?
|
| Child | 4 | 2020 | 77679 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2019 | 4041 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12961 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2279 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 6485 | 0.060 |
Why?
|
| United States | 5 | 2023 | 69867 | 0.050 |
Why?
|
| Physicians | 1 | 2020 | 4564 | 0.050 |
Why?
|
| Male | 7 | 2021 | 350027 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2023 | 778 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2019 | 6601 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 7659 | 0.040 |
Why?
|
| Head Protective Devices | 1 | 2019 | 114 | 0.040 |
Why?
|
| Algorithms | 1 | 2019 | 13885 | 0.040 |
Why?
|
| Prognosis | 2 | 2019 | 29050 | 0.040 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2019 | 239 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2021 | 1423 | 0.040 |
Why?
|
| Psychopharmacology | 1 | 2019 | 143 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20123 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15538 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2021 | 975 | 0.030 |
Why?
|
| Forecasting | 1 | 2023 | 2949 | 0.030 |
Why?
|
| Young Adult | 4 | 2021 | 56436 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 2958 | 0.030 |
Why?
|
| Outpatients | 1 | 2020 | 1486 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2014 | 23337 | 0.030 |
Why?
|
| Athletes | 1 | 2019 | 1093 | 0.030 |
Why?
|
| Attention | 1 | 2021 | 2399 | 0.020 |
Why?
|
| Antioxidants | 1 | 2019 | 1663 | 0.020 |
Why?
|
| Homeostasis | 1 | 2021 | 3339 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 2277 | 0.020 |
Why?
|
| Self Report | 1 | 2019 | 3558 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2021 | 6991 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3528 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5319 | 0.020 |
Why?
|
| Cognition | 1 | 2021 | 6765 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8628 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 9960 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2019 | 4556 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 5138 | 0.010 |
Why?
|
| Incidence | 1 | 2019 | 20945 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 39045 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 163253 | 0.000 |
Why?
|
| Middle Aged | 1 | 2020 | 213367 | 0.000 |
Why?
|
| Animals | 1 | 2016 | 168788 | 0.000 |
Why?
|